Patrick C. May

9.9k citations

92 papers · 6.6k indexed · 1 hit paper · h-index 33

Physiology top 0.2%
- Alzheimer's disease research and treatments 59
Biological Psychiatry top 1%
Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms 5
Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 25
Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research 12
Computational Theory and Mathematics
- Computational Drug Discovery Methods 23
Oncology
- Drug Transport and Resistance Mechanisms 12
Molecular Biology
- Mitochondrial Function and Pathology 6
- Amyloidosis: Diagnosis, Treatment, Outcomes 5

Co-authors: David M. Holtzman Kelly R. Bales Caleb E. Finch John R. Cirrito Steven M. Paul Ronald B. DeMattos Eric Siemers Kimberly S. Fuson
Cited by: Physiology Biological Psychiatry Neurology
Journals: Alzheimer s & Dementia (17 papers)Neurobiology of Aging (9 papers)Journal of Neurochemistry (7 papers)
Partner nations: United States United Kingdom Singapore

In The Last Decade

Patrick C. May

92 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Patrick C. May

Since Specialization

Citations

This map shows the geographic impact of Patrick C. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. May more than expected).

Fields of papers citing papers by Patrick C. May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. May. The network helps show where Patrick C. May may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick C. May, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick C. May Line = papers co-authored together Patrick C. May links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The therapeutic landscape of tauopathies: challenges and prospects Alzheimer s Research & Therapy ·Jeffrey L. Cummings,María Isabel González,Martyn C. Pritchard,Patrick C. May,Leticia Toledo‐Sherman,Glenn A. Harris	2023	31
2	A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans Alzheimer s Research & Therapy ·Mikko Hölttä,Robert A. Dean,Eric Siemers,Kwasi G. Mawuenyega,Wendy Sigurdson,Patrick C. May,David M. Holtzman,Erik Portelius,Henrik Zetterberg,Randall J. Bateman,Kaj Blennow,Johan Gobom	2016	19
3	β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage Alzheimer s Research & Therapy ·Erik Portelius,Robert A. Dean,Ulf Andréasson,Niklas Mattsson,Antônio Eugênio de Aguiar,Maria Olsson,Ronald B. DeMattos,Margaret M. Racke,Henrik Zetterberg,Patrick C. May,Kaj Blennow	2014	29
4	Safety, Tolerability, and Effects on Plasma and Cerebrospinal Fluid Amyloid-β After Inhibition of γ-Secretase Clinical Neuropharmacology ·Eric Siemers,Robert A. Dean,Stuart Friedrich,G P Schell,Celedon Gonzales,Martin R. Farlow,Patrick C. May	2007	121
5	New pathways in drug discovery for alzheimer’s disease Current Neurology and Neuroscience Reports ·Eric Siemers,Robert A. Dean,Ronald B. DeMattos,Patrick C. May	2006	10
6	Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivobreakdown → Neuron ·John R. Cirrito,Kelvin A. Yamada,Mary Beth Finn,Robert S. Sloviter,Kelly R. Bales,Patrick C. May,Darryle D. Schoepp,Steven M. Paul,Steven Mennerick,David M. Holtzman	2005	1003
7	A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes Journal of Neurochemistry ·Liang Yu,Suizhen Lin,Thomas P. Beyer,Youyan Zhang,Xin Wu,Kelly R. Bales,Ronald B. DeMattos,Patrick C. May,Kraev Bg,Xian‐Cheng Jiang,Patrick I. Eacho,Guoqing Cao,Steven M. Paul	2004	135
8	Biochemical and kinetic characterization of BACE1: investigation into the putative species‐specificity for β‐ and β′‐cleavage sites by human and murine BACE1 Journal of Neurochemistry ·Hsiu‐Chiung Yang,Xiyun Chai,Marian Mosior,Wayne D. Kohn,Leonard N. Boggs,Jon A. Erickson,Don B. McClure,Martin L. Morin,房子石岡,Patricia A. Gonzalez‐DeWhitt,John P. Mayer,Kai-An You,Jingdan Hu,Shuhui Chen,Ana B. Bueno,Sheila P. Little,James McCarthy,Patrick C. May	2004	11
9	Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor Journal of Biological Chemistry ·George H. Searfoss,William H. Jordan,David O. Calligaro,Elizabeth J. Galbreath,R.N. Saifullin,Brian R. Berridge,Hong Gao,Marnie A. Higgins,Patrick C. May,Timothy P. Ryan	2003	258
10	P3 cap modified Phe-Ala series BACE inhibitors Bioorganic & Medicinal Chemistry Letters* ·Shuhui Chen,Yang Lu,溝口明,Todd J. Kohn,Hsiu‐Chiung Yang,J McGee,David E. Timm,Jon A. Erickson,Chang Sheng Lin,Patrick C. May,J. Michael McCarthy	2003	17
11	Phe-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR Bioorganic & Medicinal Chemistry Letters* ·Yang Lu,Jingdan Hu,Ana B. Bueno,Hsiu‐Chiung Yang,溝口明,胡银岗,J McGee,Bruce D. Gitter,David E. Timm,Patrick C. May,J. Michael McCarthy,Shuhui Chen	2003	26
12	Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5 FEBS Letters ·Feng Liu,Su Yuan,Baolin Li,Yan Zhou,John Ryder,Patricia A. Gonzalez‐DeWhitt,Patrick C. May,Binhui Ni	2003	86
13	Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonists against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures Neuroscience Letters ·Patrick C. May,Amplitude Estimation,Kimberly S. Fuson	1999	16
14	Fibroblast growth factor-8 protects cultured rat hippocampal neurons from oxidative insult Brain Research ·Robert J. Mark,Kimberly S. Fuson,Alex Lasnier,Patrick C. May	1999	22
15	Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity Journal of Neurochemistry ·Leonard N. Boggs,Kimberly S. Fuson,Melvyn Baez,Lisa M. Churgay,Don B. McClure,Gerald L. Becker,Patrick C. May	1996	92
16	Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes Brain Research ·Diane Stephenson,Joseph Manetta,D. L. White,X. Grace Chiou,Laura M. Cox,Bruce D. Gitter,Patrick C. May,John Sharp,Ruth M. Kramer,James A. Clemens	1994	76
17	Sulfated Glycoprotein‐2: An Emerging Molecular Marker for Neurodegeneration Annals of the New York Academy of Sciences ·Patrick C. May	1993	17
18	Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity Journal of Neurochemistry ·Patrick C. May,Leonard N. Boggs,Kimberly S. Fuson	1993	109
19	Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning Molecular Brain Research ·Judes Poirier,Mark A. Hess,Patrick C. May,Caleb E. Finch	1991	327
20	Rapid Corticosterone-lnduced Changes in Gene Expression in Rat Hippocampus Display Type II Glucocorticoid Receptor Specificity Molecular Endocrinology ·Nancy R. Nichols,S.P. Lerner,Jeffrey N. Masters,Patrick C. May,A. Rossbach,Caleb E. Finch	1988	29

About Patrick C. May

Patrick C. May is a scholar working on Physiology, Pharmacology, Computational Theory and Mathematics, Biological Psychiatry and Cellular and Molecular Neuroscience, having authored 92 papers that have together received 6.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (59 papers), Cholinesterase and Neurodegenerative Diseases (25 papers), Computational Drug Discovery Methods (23 papers), Drug Transport and Resistance Mechanisms (12 papers), Neuroscience and Neuropharmacology Research (12 papers), Mitochondrial Function and Pathology (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). The work is most often cited by research in Physiology (4.6k citations), Biological Psychiatry (332 citations), Neurology (943 citations), Pharmacology (1.5k citations) and Cellular and Molecular Neuroscience (1.5k citations). Patrick C. May has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include David M. Holtzman, Kelly R. Bales, Caleb E. Finch, John R. Cirrito, Steven M. Paul, Ronald B. DeMattos, Eric Siemers, Kimberly S. Fuson, Judes Poirier and Darryle D. Schoepp. Their work appears in journals such as Alzheimer s & Dementia, Neurobiology of Aging, Journal of Neurochemistry, Alzheimer s Research & Therapy and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact